These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4803643)

  • 41. Iatrogenic ototoxic hearing loss.
    Nilges TC; Northern JL
    Ann Surg; 1971 Feb; 173(2):281-9. PubMed ID: 4100191
    [No Abstract]   [Full Text] [Related]  

  • 42. [V: [Clinical and experimental studies with gentamicin]].
    Kusák V
    Cas Lek Cesk; 1970 Apr; 109(17):385-8. PubMed ID: 4910130
    [No Abstract]   [Full Text] [Related]  

  • 43. Experience with gentamicin and specialty use of gentamicin. Gentamicin: laboratory and clinical experience in Mexico.
    Escárzaga E
    J Infect Dis; 1969; 119(4):443-7. PubMed ID: 4977997
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative study of the nephrotoxicity of gentamicin with constant and intermittent administration of the antibiotic].
    Ruilope LM; Torres A; Hernando L; Ales JM
    Rev Clin Esp; 1974 Apr; 133(2):119-24. PubMed ID: 4844766
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical contribution to the use of methacycline in pediatrics].
    Spagnuolo C; Klain U; Cioffi V
    Pediatria (Napoli); 1967; 75(4):594-609. PubMed ID: 5586717
    [No Abstract]   [Full Text] [Related]  

  • 46. [Penetracyne in powder form in current pediatric practice].
    Vitiello J
    Mars Med; 1966; 103(7):591-3. PubMed ID: 4968499
    [No Abstract]   [Full Text] [Related]  

  • 47. Ototoxicity of gentamicin. Histopathologic and functional results in the cat.
    Webster JC; McGee TM; Carroll R; Benitez JT; Williams ML
    Trans Am Acad Ophthalmol Otolaryngol; 1970; 74(6):1155-65. PubMed ID: 5312832
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical considerations on a new synthetic compound with antipyretic and anticatarrhal action].
    D'Urso G; Lax I
    Minerva Med; 1981 Feb; 72(7):367-9. PubMed ID: 7243038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pyrrolidino-methyl-tetracycline. On its use in early childhood].
    Bezante T
    Minerva Pediatr; 1966 Sep; 18(26):1435-8. PubMed ID: 5994485
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin.
    Wagner N; Cayé-Thomasen P; Laurell G; Bagger-Sjöbäck D; Thomsen J
    Acta Otolaryngol; 2005 Apr; 125(4):340-5. PubMed ID: 15823802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of intratympanic gentamicin on hearing and tinnitus in Meniere's disease.
    Eklund S; Pyykkö I; Aalto H; Ishizaki H; Vasama JP
    Am J Otol; 1999 May; 20(3):350-6. PubMed ID: 10337977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ototoxicity of topically applied gentamicin using a statistical analysis of electrophysiological measurement.
    Morizono T; Johnstone BM
    Acta Otolaryngol; 1975; 80(5-6):389-93. PubMed ID: 1202914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
    Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gentamicin and deafness].
    Conde Jahn F
    Acta Otorinolaryngol Iber Am; 1973; 24(2):106-8. PubMed ID: 4803643
    [No Abstract]   [Full Text] [Related]  

  • 56. [Deafness and gentallin].
    Martin H; Gadot P; Gignoux B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Apr; 21(4):335-8. PubMed ID: 4262089
    [No Abstract]   [Full Text] [Related]  

  • 57. Ototoxicity resulting from combined administration of cisplatin and gentamicin.
    Kohn S; Fradis M; Podoshin L; David YB; Zidan J; Robinson E; Nir I
    Laryngoscope; 1997 Mar; 107(3):407-8. PubMed ID: 9121325
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.